The Economic Benefits of PROKERA®

It’s not a simple cliché or abstraction to state, for the record, that the best, most profitable, and most enduring business plan is simply, and above all else, doing the best for the patient. Hence, when considering the economics of PROKERA® use in practice, we must ensure that we are making calculations based on the appropriate metrics. Are we considering only the myopic calculation of price and profit-margin; erroneously rationalizing that an amniotic membrane is an amniotic membrane?

Or, are we, our patients, and our long-term practice prospects, better off, by focusing on endpoints like quality of healing, speed of healing, and the other metrics of efficiency, time, and profitability that they directly and indirectly impact? In this blog, I will address the rationale (both economic and medical) behind our decision to use the PROKERA-line in my Cornea, Cataract, and Refractive practice.

Preparing the Ocular Surface for Cataract Surgery

The condition of a patient’s ocular surface prior to cataract surgery, particularly refractive cataract surgery, can greatly impact the outcome. This is especially true for patients with dry eye and/or mild or severe epithelial basement membrane dystrophy (EBMD). Both of these conditions are so prevalent, they can be easy to overlook. I was taught in residency, 10% of the population, but if you look at the studies, it's widely variable. Some studies are upwards of 30 to 40% of the population.